The Chan Zuckerberg Biohub has announced a major $500 million initiative to develop artificial intelligence models that can simulate how human cells work, in a move aimed at transforming biomedical research and drug discovery.
The project, called the Virtual Biology Initiative, will run over five years and focuses on building highly detailed “digital models” of human cells. These AI systems are expected to help scientists better understand how diseases develop and how they might be treated or prevented.
The funding will be split into two main parts. Around $400 million will be used by Biohub itself to develop advanced technologies, including high-resolution imaging tools, molecular engineering methods, and large-scale data systems. The remaining $100 million will support external research teams working on global data collection and related scientific projects.
The initiative brings together a wide network of leading institutions and research organisations, including MIT’s Broad Institute, Harvard-linked groups, the Allen Institute, the Wellcome Sanger Institute, and international projects like the Human Cell Atlas. Technology companies such as NVIDIA are also involved, providing computing power and AI infrastructure needed to process massive biological datasets.
Researchers involved in the project say one of the biggest challenges in modern biology is the lack of enough high-quality data about how cells behave in different conditions. The goal is to generate vast, standardized datasets that can be used to train AI systems capable of predicting cellular behaviour more accurately.
Also Read: Russia, Ukraine announce rival ceasefires ahead of Victory Day
